Cited by 574

The DOI matches its Crossref record; 449 of the 449 references it cites were found in a registry or an index.

NF‐κB signaling in inflammation and cancer

Open access

Zhang, Tao, Ma, Chao, Zhang, Zhiqiang, Zhang, Huiyuan, Hu, Hongbo·2021·MedComm

Open this paper in CoChat — free account

Abstract

Since nuclear factor of κ‐light chain of enhancer‐activated B cells (NF‐κB) was discovered in 1986, extraordinary efforts have been made to understand the function and regulating mechanism of NF‐κB for 35 years, which lead to significant progress. Meanwhile, the molecular mechanisms regulating NF‐κB activation have also been illuminated, the cascades of signaling events leading to NF‐κB activity and key components of the NF‐κB pathway are also identified. It has been suggested NF‐κB plays an important role in human diseases, especially inflammation‐related diseases. These studies make the NF‐κB an attractive target for disease treatment. This review aims to summarize the knowledge of the family members of NF‐κB, as well as the basic mechanisms of NF‐κB signaling pathway activation. We will also review the effects of dysregulated NF‐κB on inflammation, tumorigenesis, and tumor microenvironment. The progression of the translational study and drug development targeting NF‐κB for inflammatory diseases and cancer treatment and the potential obstacles will be discussed. Further investigations on the precise functions of NF‐κB in the physiological and pathological settings and underlying mechanisms are in the urgent need to develop drugs targeting NF‐κB for inflammatory diseases and cancer treatment, with minimal side effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/mco2.104

Cites

449 of 449 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

Items 401–449 of 449

Environmental Triggers for IBD
O’Toole, A., & Korzenik, J. R. (2014) · Current Gastroenterology Reports · doi:10.1007/s11894-014-0396-y · Cited by 44
A Cell-Intrinsic Requirement for NF-κB–Inducing Kinase in CD4 and CD8 T Cell Memory
Rowe, A. M., Murray, S., Raué, H.-P., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301328 · Cited by 44
Role of the NFKB1 −94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes
Glas, J., Török, H., Tonenchi, L., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.ibd.0000225346.23765.6b · Cited by 43
Constitutive Production of NF-κB2 p52 Is Not Tumorigenic but Predisposes Mice to Inflammatory Autoimmune Disease by Repressing Bim Expression
Wang, Z., Zhang, B., Yang, L., Ding, J., & Ding, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800806200 · Cited by 43
The NFκB-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing γδ T cells
Mair, F., Joller, S., Hoeppli, R. E., Onder, L., Hahn, M., Ludewig, B., Waisman, A., & Becher, B. (2015) · eLife · doi:10.7554/elife.10087 · Cited by 43
Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway
Luo, L., Rao, L., Luo, L., Chen, K., Ran, R., & Liu, X. (2019) · Microvascular Research · doi:10.1016/j.mvr.2019.103968 · Cited by 43
Paeonia lactiflora Root Extract and Its Components Reduce Biomarkers of Early Atherosclerosis via Anti-Inflammatory and Antioxidant Effects In Vitro and In Vivo
Kim, M. J., Kang, H.-H., Seo, Y. J., Kim, K., Kim, Y., & Jung, S. K. (2021) · Antioxidants · doi:10.3390/antiox10101507 · Cited by 40
Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production
Kubo, M., Morisaki, T., Matsumoto, K., Tasaki, A., Yamanaka, N., Nakashima, H., Kuroki, H., Nakamura, K., Nakamura, M., & Katano, M. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0617-6 · Cited by 39
Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis
Vinay, D. S., & Kwon, B. S. (2011) · Cytokine · doi:10.1016/j.cyto.2011.12.005 · Cited by 38
Genetic Determinants Associated With Early Age of Diagnosis of IBD
Connelly, T. M., Berg, A. S., Harris, L., Brinton, D. L., Deiling, S. M., & Koltun, W. A. (2015) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000274 · Cited by 38
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
Raizer, J. J., Chandler, J. P., Ferrarese, R., Grimm, S. A., Levy, R. M., Muro, K., Rosenow, J. M., Helenowski, I., RADEMAKER, A. W., Paton, M., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2156-3 · Cited by 38
Activation of NF-kB Pathway by Virus Infection Requires Rb Expression
García, M. Á., Gallego, P. P. F., Campagna, M., González, J., Martinez, G. M., Marcos-Villar, L., Vidal, A., Estéban, M., & Rivas, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006422 · Cited by 37
The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis
Charostad, J., Nakhaie, M., Dehghani, A., & Faghihloo, E. (2020) · Infectious Agents and Cancer · doi:10.1186/s13027-020-00317-4 · Cited by 37
CD4+T Cell Fate in Glomerulonephritis: A Tale of Th1, Th17, and Novel Treg Subtypes
Krebs, C. F., & Steinmetz, O. M. (2016) · Mediators of Inflammation · doi:10.1155/2016/5393894 · Cited by 36
Myeloid IκBα Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques
Goossens, P., Vergouwe, M. N., Gijbels, M. J., Curfs, D. M. J., van Woezik, J. H. G., Hoeksema, M. A., Xanthoulea, S., Leenen, P. J. M., Rupec, R. A., Hofker, M. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022327 · Cited by 35
NF-kappaB-inducing kinase in cancer
Maubach, G., Feige, M. H., Lim, M. C. C., & Naumann, M. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.10.002 · Cited by 35
Inhibition of Nuclear Factor Kappa B activation in Early-Stage Chronic Lymphocytic Leukemia by Omega-3 Fatty Acids
Fahrmann, J. F., Ballester, O. F., Ballester, G., Witte, T. R., Salazar, A. J., Kordusky, B., Cowen, K. G., Ion, G., Primerano, D. A., Bošković, G., et al. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.743553 · Cited by 34
TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex
Shi, J., & Sun, S. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.024 · Cited by 32
Macrophages and NF-κB in Cancer
Lawrence, T. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_100 · Cited by 32
Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection
Evaristo, C., Spranger, S., Barnes, S. E., Miller, M. L., Molinero, L. L., Locke, F. L., Gajewski, T. F., & Alegre, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501144 · Cited by 32
Autoimmunity in Crohn's Disease—A Putative Stratification Factor of the Clinical Phenotype
Roggenbuck, D., Reinhold, D., Baumgart, D. C., Schierack, P., Conrad, K., & Laass, M. W. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.06.002 · Cited by 32
What Are the Targets of Inflammatory Bowel Disease Management
Lega, S., & Dubinsky, M. C. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy064 · Cited by 32
Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology
Li, J., Bao, J., Zeng, J., Yan, A., Zhao, C., & Shu, Q. (2019) · Bone Research · doi:10.1038/s41413-019-0067-6 · Cited by 32
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
Drilon, A., Schoenfeld, A. J., Arbour, K. C., Litvak, A., Ni, A., Montecalvo, J., Yu, H. A., Panora, E., Ahn, L., Kennedy, M., et al. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003665 · Cited by 31
Tumor Angiogenesis, Macrophages, and Cytokines
Bando, H., & Toi, M. (2000) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4221-6_21 · Cited by 30
LAT signaling pathology: an “autoimmune” condition without T cell self-reactivity
Roncagalli, R., Mingueneau, M., Grégoire, C., Malissen, M., & MALISSEN, B. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.05.001 · Cited by 30
Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-κB signaling pathway
Feng, Y., Zhu, B., Liu, Y., Liu, Y., Zhou, G., Li, Y., Liu, L., Ren, J., Hou, Y., Yu, H., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153784 · Cited by 29
Cell-Intrinsic Role for NF-kappa B-Inducing Kinase in Peripheral Maintenance but Not Thymic Development of Foxp3+ Regulatory T Cells in Mice
Murray, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076216 · Cited by 28
FOXP3 inhibits cancer stem cell self-renewal via transcriptional repression of COX2 in colorectal cancer cells
Liu, S., Zhang, C., Zhang, K., Gao, Y., Wang, Z., Li, X., Cheng, G., Wang, S., Xue, X., Li, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17974 · Cited by 28
Protein ubiquitination in lymphoid malignancies
Yang, Y., & Staudt, L. M. (2014) · Immunological Reviews · doi:10.1111/imr.12247 · Cited by 27
Les facteurs de transcription Rel/NF-B : rôle complexe dans les régulations cellulaires
Bottex, C., Pollet, S., Favier, A. E., & Vidal, D. R. (2002) · Pathologie Biologie · doi:10.1016/s0369-8114(02)00289-4 · Cited by 26
The complicated role of NF-κB in T-cell selection
Zhu, M., & Fu, Y. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.112 · Cited by 24
Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway
Dejban, P., Rahimi, N., Takzare, N., & Dehpour, A. R. (2020) · Pharmacological Reports · doi:10.1007/s43440-019-00054-5 · Cited by 24
Apoptosis Induced by (+)-Betulin Through NF-κB Inhibition in MDA-MB-231 Breast Cancer Cells
Anaya‐Eugenio, G. D., EGGERS, N. A., Ren, Y., Rivera‐Chávez, J., Kinghorn, A. D., & de Blanco, E. J. C. (2020) · Anticancer Research · doi:10.21873/anticanres.14688 · Cited by 24
SARS-CoV-2 infection and the antiviral innate immune response
Yang, H., Lyu, Y., & Hou, F. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa071 · Cited by 22
Clinical benefit of ixazomib plus lenalidomide‐dexamethasone in myeloma patients with non‐canonical NF‐κB pathway activation
Dash, A. B., Zhang, J., Shen, L., Li, B., Berg, D. T., Lin, J., Avet‐Loiseau, H., Bahlis, N. J., Moreau, P., Richardson, P. G. G., et al. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13435 · Cited by 21
Single cell whole genome sequencing reveals that NFKB1 mutation affects radiotherapy sensitivity in cervical cancer
Yang, D., Zhang, W., Liang, J., Ma, K., Chen, P., Lu, D., & Hao, W. (2017) · Oncotarget · doi:10.18632/oncotarget.23587 · Cited by 20
Combined loss of cRel/p50 subunits of NF-κB leads to impaired innate host response in sepsis
Courtine, E., Cagnard, N., Mazzolini, J., Antona, M., Pène, F., Fitting, C., Jacques, S., Rousseau, C., Niedergang, F., Gerondakis, S., et al. (2012) · Innate Immunity · doi:10.1177/1753425912440296 · Cited by 19
Diosmectite inhibits the interaction between SARS-CoV-2 and human enterocytes by trapping viral particles, thereby preventing NF-kappaB activation and CXCL10 secretion
Poeta, M., Cioffi, V., Buccigrossi, V., Nanayakkara, M., Baggieri, M., Peltrini, R., Amoresano, A., Magurano, F., & Guarino, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-01217-2 · Cited by 19
Murine models of germinal center derived-lymphomas
Ramezani-Rad, P., & Rickert, R. C. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.12.002 · Cited by 16
RelB-Deficient Dendritic Cells Promote the Development of Spontaneous Allergic Airway Inflammation
Nair, P. M., Starkey, M. R., Haw, T. J., Ruscher, R., Liu, G., Maradana, M. R., Thomas, R., O’Sullivan, B., & Hansbro, P. M. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0242oc · Cited by 16
Transcription factor NF-κB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model
Kanan, T., Kanan, D., Shardoub, E. J. A., & Durdağı, S. (2021) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2021.107968 · Cited by 16
OsteoRheumatology: a new discipline?
Favero, M., Giusti, A., Geusens, P., Goldring, S. R., Lems, W. F., Schett, G. A., & Bianchi, G. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000083 · Cited by 15
Visualization of RelB expression and activation at the single-cell level during dendritic cell maturation inRelb-Venusknock-in mice
Seki, T., Yamamoto, M., Taguchi, Y., Miyauchi, M., Akiyama, N., Yamaguchi, N., Gohda, J., Akiyama, T., & Inoue, J. (2015) · The Journal of Biochemistry · doi:10.1093/jb/mvv064 · Cited by 13
Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
Patanè, M., Porrati, P., Bottega, E., Morosini, S., Cantini, G., Girgenti, V., Rizzo, A., Eoli, M., Pollo, B., Sciacca, F. L., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-160 · Cited by 13
TBK1 suppression of IgA in the NIK of time
Bram, R. J. (2012) · Nature Immunology · doi:10.1038/ni.2451 · Cited by 11
Autoimmunity in 2018
Selmi, C. F. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08745-w · Cited by 10
Patients with ulcerative colitis responding to steroid treatment up-regulate glucocorticoid receptor levels in colorectal mucosa
Flood, L., Innala, E., Löfberg, R., & Wikström, A. C. (2007) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2007.10.002 · Cited by 6
Oncogenic mutations in IKKβ function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation
Meyer, A. N., Gallo, L. H., Ko, J., Cardenas, G., Nelson, K. N., Siari, A., Campos, A. R., Whisenant, T. C., & Donoghue, D. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206014 · Cited by 4

Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Casein Kinase 1α—A Target for Prostate Cancer Therapy?
Lishman-Walker, E., & Coffey, K. (2024) · Cancers · doi:10.3390/cancers16132436 · Cited by 4

See all 574

Authors: Zhang, T., Ma, C., Zhang, Z., Zhang, H., & Hu, H.
Venue: MedComm
Publisher: Wiley
Published: 2021-12
Volume: 2
Issue: 4
Pages: 618-653
ISSN: 2688-2663 (ISSN-L)
DOI: 10.1002/mco2.104
OpenAlex: W4200459954
Cited by: 574
References: 449
FWCI: 20.13
Type: journal article
Language: en
Open access: gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

NF‐κB signaling in inflammation and cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources